Skip to main content

Wound Dressings: Procurement

Question for Department of Health

UIN HL4799, tabled on 22 December 2015

To ask Her Majesty’s Government how they plan to ensure that, in the implementation of the NHS Supply Chain generic project plans for a national formulary for wound care, innovative small companies are not at a disadvantage in bidding for contracts.

Answered on

4 January 2016

Innovation is welcomed as part of this process and the clinical specifications may support smaller companies who demonstrate their capability to meet the requirements. One advantage of the NHS Supply Chain venture for smaller companies is that it can act as a single point of entry into the National Health Service and lower the ‘cost of sales’.